Professional Overview
Duygu Citak is a seasoned professional in the clinical operations sector, currently serving as a Clinical Operations Lead. Her key expertise areas include clinical research, study management, and team leadership, with a strong industry focus on pharmaceuticals and healthcare.
Experience Summary
Current Role
As the Clinical Operations Lead at Roche, Duygu is responsible for overseeing clinical trials, managing study start-ups, and ensuring compliance with regulatory requirements. Her achievements in this role include successful trial management and team leadership. The impact of her work is evident in the efficient execution of clinical trials, contributing to the development of new treatments.
Career Progression
Duygu's career progression is marked by steady growth and increasing responsibility. Notable previous roles include Country Study Manager at Roche, Executive Clinical Research Associate at IQVIA, and Senior Clinical Research Associate at IQVIA. Her career trajectory demonstrates a commitment to clinical research and operations, with key achievements in study management, team leadership, and regulatory compliance.
Academic Background
Duygu holds a Master of Science (M.Sc.) in Organic Chemistry from Boğaziçi University. Her academic background also includes a Bachelor of Science (BSc) in Chemistry from the same institution and an experience in Organic Chemistry from RWTH Aachen University.
Areas of Expertise
Duygu's areas of expertise include clinical research, study management, regulatory compliance, team leadership, and project management. Her technical competencies encompass a deep understanding of clinical trial operations, and she possesses strong leadership and management capabilities.
Professional Impact
While specific project details are not available, Duygu's contributions to the pharmaceutical industry are significant. Her work in clinical trials has likely impacted the development and approval of new treatments, improving patient outcomes.
Conclusion
Duygu Citak's professional trajectory is marked by a consistent focus on clinical operations and research. Currently, as a Clinical Operations Lead, she continues to make significant contributions to the pharmaceutical industry. Her value proposition lies in her expertise, leadership capabilities, and commitment to the advancement of clinical research and healthcare.
